A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes

연구 개요

The main purpose of this study is to see how orforglipron, compared with placebo, helps improve glycemic control in participants with obesity or with overweight and type 2 diabetes. This trial is part of the master protocol study J2A-MC-GZPO (NCT06993792). Participation in the study will last about 18 months.